Find policies, billing codes, payers, states, and providers
HCPCS G0124: Cervical/Vaginal Screening Cytopathology, Thin-Layer
HCPCS Level II code G0124 covers physician-interpreted screening cytopathology of the cervix or vagina when specimens are collected in preservative fluid and processed with an automated thin-layer preparation. Nationally, this code is part of routine cervical cancer screening workflows and laboratory billing for gynecologic cytology. It matters because screening modality and preparation method can affect laboratory workflows, coding specificity, and payer coverage policies.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, typical sites of service, and the clinical context for automated thin-layer cytology screening. The publication summarizes common billing considerations, frequently used modifiers (listed separately), and how G0124 relates to laboratory service lines.
The report provides national benchmarks where available, notes relevant policy and coverage themes affecting screening cytology, and clarifies clinical context for use of automated thin-layer preparations. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for hcpcs G0124 policy alerts
Get alerted when payer policies referencing G0124 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code G0124 describes screening cytopathology of the cervix or vagina collected in preservative fluid and prepared using an automated thin layer preparation method. The service requires interpretation by a physician and is intended for cytologic screening rather than diagnostic or therapeutic procedures.
-
Service type: Laboratory screening cytopathology using automated thin-layer preparation
-
Typical site of service: Clinical laboratory or outpatient laboratory facility